Clinical Trial Update: A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection [NA]

View source ↗

Summary

A small, open-label pilot trial evaluating a combination of stavudine, didanosine, nelfinavir, and hydroxyurea in people with recent HIV infection; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Didanosine (didanosine)
• HYDROXYUREA (Hydroxyurea)
• Nelfinavir (nelfinavir)
• stavudine (stavudine)

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: HIV Infections | NA | Status: COMPLETED